Perfusion CT findings in patients with metastatic carcinoid tumors undergoing bevacizumab and interferon therapy.

@article{Ng2011PerfusionCF,
  title={Perfusion CT findings in patients with metastatic carcinoid tumors undergoing bevacizumab and interferon therapy.},
  author={Chaan S. Ng and Chuslip Charnsangavej and Wei Wei and James C. Yao},
  journal={AJR. American journal of roentgenology},
  year={2011},
  volume={196 3},
  pages={569-76}
}
OBJECTIVE The purpose of this article is to assess tumor changes on perfusion CT with bevacizumab and interferon (IFN) therapy in patients with metastatic carcinoid tumors and to evaluate perfusion CT differences between the two therapies. SUBJECTS AND METHODS In a phase 2 clinical trial, 44 patients were randomized to receive monotherapy with bevacizumab or IFN for 18 weeks (stage 1), followed by dual-therapy with both drugs (stage 2). Twenty-four patients consented to have optional… CONTINUE READING